Children with sickle cell disease (SCD) had more emergency department (ED) visits if their parents had a greater number of adverse childhood experiences (ACEs) than if their parents had fewer ACEs ...
Global Blood Therapeutics Inc (NASDAQ: GBT) has submitted a supplemental marketing application to the FDA seeking accelerated approval for Oxbryta (voxelotor) for the treatment of Sickle Cell Disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback